School of Medicine
Showing 381-400 of 4,265 Results
-
Hind Bouzid
Program Manager, Medical Genetics, Pediatrics - Genetics
BioDr. Hind Bouzid received a BS and MS in Genetics from Université Paris Diderot, France. She then joined Gustave Roussy Cancer Institute, where she pursued a PhD in Hematology/Oncology, studying the genetic mechanisms underlying the progression of inherited hematologic disorders to leukemia.
She subsequently conducted research in hematopoietic stem cell gene therapy at Dana-Farber Cancer Institute, followed by postdoctoral training at Stanford University, where she studied clonal hematopoiesis in the context of neurodegenerative disease. She later transitioned to biotechnology, working in translational medicine with a focus on biomarker strategies and early-phase clinical trials for immune-mediated diseases.
Passionate about rare genetic diseases and translational medicine, Dr. Bouzid is dedicated to advancing innovative research and fostering multidisciplinary collaborations that accelerate scientific discovery and clinical progress. -
Nicholas Branigan
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioMy research interests are at the intersection of neuroscience, statistics, and machine learning. In my current work, I develop and apply state-space models and drift-diffusion models to study large-scale brain networks with human fMRI and rodent fiber photometry.
-
Jessica Yelena Breland, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psych/Public Mental Health & Population SciencesBioJessica Breland, MS, PhD is a licensed psychologist and a Core Investigator at the Center for Innovation to Implementation in the VA Palo Alto Health Care System. Dr. Breland received her PhD in psychology from Rutgers and completed her clinical internship at the Baylor College of Medicine in Houston, TX.
Her work focuses on using quantitative and qualitative methods to: 1) assess outcomes related to the implementation of evidenced-based treatments, especially through controlled trials in novel settings (e.g., primary care) or with novel methods (e.g., apps); 2) identify and reduce racial and ethnic disparities in health; and 3) enhance care for patients with chronic conditions, such as obesity or diabetes.